Yee-Sin Leo to Treatment Outcome
This is a "connection" page, showing publications Yee-Sin Leo has written about Treatment Outcome.
Connection Strength
0.092
-
Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial. Lancet. 2017 04 22; 389(10079):1611-1618.
Score: 0.025
-
Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003. Trop Med Int Health. 2004 Aug; 9(8):923-7.
Score: 0.011
-
Severe acute respiratory syndrome (SARS) in Singapore: clinical features of index patient and initial contacts. Emerg Infect Dis. 2003 Jun; 9(6):713-7.
Score: 0.010
-
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir. Front Immunol. 2021; 12:680188.
Score: 0.009
-
Risk Factors for Severe Disease and Efficacy of Treatment in Patients Infected With COVID-19: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis. Clin Infect Dis. 2020 11 19; 71(16):2199-2206.
Score: 0.008
-
Healthcare workers in Singapore infected with COVID-19: 23 January-17 April 2020. Influenza Other Respir Viruses. 2021 03; 15(2):218-226.
Score: 0.008
-
Remdesivir for severe covid-19: a clinical practice guideline. BMJ. 2020 07 30; 370:m2924.
Score: 0.008
-
Development of standard clinical endpoints for use in dengue interventional trials. PLoS Negl Trop Dis. 2018 10; 12(10):e0006497.
Score: 0.007
-
The immune response to 6-monthly versus annual standard dose inactivated trivalent influenza vaccination in older people: study protocol for a randomised clinical trial. Trials. 2017 02 10; 18(1):67.
Score: 0.006